Fibrocell Science, Inc. Receivables Turnover Ratio (FCSC), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fibrocell Science, Inc.  (FCSC)
 

Fibrocell Science Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Fibrocell Science, Inc.'s ability to collect accounts receivable sequentially worsen to 20.74, indicating more challenging environment then in the second quarter 2019, but still, it is a far cry from any concerns. Fibrocell Science's Accounts Receivable average collection period in the Sep 30 2019 quarter, has increased to 18 days, from 9 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 100 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 586 to 1134.

What is Receivable Turnover Ratio?
What is Fibrocell Science, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FCSC Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 1071.26 % 8904.96 % - - -
Receivable Turnover Ratio (TTM) 20.74 42.8 27.84 - -
FCSC's Total Ranking # 1134 # 586 # 323 # 1112 # 0
Accounts Receivable average collection period days 18 9 13 - -
Seq. Receivable Change 32.13 % 550 % - - -
Seq. Revenue Change -95.32 % 39521.82 % -96.69 % 1810.34 % -64.05 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 101
Overall Market # 1134

Receivable Turnover Ratio Statistics
High Average Low
1.09 0.14 0
(Jun 30 2019)   (Sep 30 2014)





FCSC Company Profile • Back to FCSC Efficiency Comparisons • Compare FCSC Receivables Turnover Ratio to its Competitors

Financial Statements
Fibrocell Science's Accounts Receivable $ 3 Millions Visit FCSC's Balance sheet
Fibrocell Science's Sales TTM $ 25 Millions Visit FCSC's Income Statement
Sources of FCSC's Revenues Visit FCSC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FCSC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FCSC's Growth Rates FCSC's Roa FCSC's Inventory Turnover Ratio FCSC's Dividend Comparisons
FCSC's Profitability Ratios FCSC's Roi FCSC's Asset Turnover Ratio FCSC's Dividend Growth
FCSC's Valuation Ratios FCSC's Roe FCSC's Financial Strength Ratios FCSC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Creative Medical Technology Holdings Inc   25.81 $ 0.227  Millions$ 0.009  Millions
Dariohealth Corp   24.52 $ 7.461  Millions$ 0.304  Millions
Endonovo Therapeutics Inc   24.44 $ 0.204  Millions$ 0.008  Millions
Cytomx Therapeutics Inc   23.91 $ 60.681  Millions$ 2.538  Millions
Igc Pharma Inc   23.44 $ 6.297  Millions$ 0.269  Millions
Ernexa Therapeutics Inc   23.42 $ 20.541  Millions$ 0.877  Millions
Cormedix Inc   23.15 $ 0.285  Millions$ 0.012  Millions
Ibio inc   22.87 $ 2.081  Millions$ 0.091  Millions
Hutchmed china Limited  22.73 $ 520.020  Millions$ 22.875  Millions
Verastem Inc   22.49 $ 25.049  Millions$ 1.114  Millions
Harrow Inc   21.84 $ 49.945  Millions$ 2.287  Millions
Tearlab Corp  20.98 $ 22.997  Millions$ 1.096  Millions
Fibrocell Science, Inc.  20.74 $ 24.528  Millions$ 1.182  Millions
Momenta Pharmaceuticals inc   20.58 $ 58.508  Millions$ 2.843  Millions
Uniqure N v   19.31 $ 7.054  Millions$ 0.365  Millions
Wearable Health Solutions, Inc.  19.01 $ 0.903  Millions$ 0.048  Millions
Lexicon Pharmaceuticals Inc   18.17 $ 330.417  Millions$ 18.184  Millions
Fresenius Medical Care Ag  17.57 $ 30,991.056  Millions$ 1,763.854  Millions
Immunogen inc   17.26 $ 52.250  Millions$ 3.028  Millions
Axim Biotechnologies Inc   16.86 $ 0.680  Millions$ 0.040  Millions
Aveo Pharmaceuticals Inc   16.41 $ 29.947  Millions$ 1.825  Millions
Acadia Healthcare Company Inc   16.31 $ 5,490.769  Millions$ 336.663  Millions
Vtv Therapeutics Inc   15.89 $ 7.279  Millions$ 0.458  Millions
Therapeutic Solutions International Inc   15.46 $ 0.021  Millions$ 0.001  Millions
Chemed Corporation  15.31 $ 1,873.739  Millions$ 122.418  Millions
Cv Sciences Inc   15.28 $ 58.592  Millions$ 3.835  Millions
Seres Therapeutics Inc   15.02 $ 37.512  Millions$ 2.497  Millions
Mannkind Corporation  14.98 $ 63.077  Millions$ 4.211  Millions
Kyntra Bio Inc   14.96 $ 356.657  Millions$ 23.846  Millions
Ainos Inc   14.72 $ 0.015  Millions$ 0.001  Millions

Date modified: 2026-06-22T14:32:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.